Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage

Current — Mylan Institutional, A Viatris Company

The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Mylan Institutional, A Viatris Company with status Current. The shortage was first posted on Apr 10, 2020.

Shortage details

Status
Current
Company
Mylan Institutional, A Viatris Company
Package NDC
67457-251-02
Dosage Form
Injection
Presentation
Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02)
Initial Posting
Apr 10, 2020

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.